Raiffeisen Bank International’s Beam Therapeutics BEAM Stock Holding History

Raiffeisen Bank International’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$986K	Buy	45,000 +2,000	+5%	+$55.5K	0.01%	388
2025 Q4	$1.2M	Hold	43,000	–	–	0.02%	323
2025 Q3	$1.03M	Buy	43,000 +8,000	+23%	+$159K	0.01%	333
2025 Q2	$587K	Hold	35,000	–	–	0.01%	360
2025 Q1	$777K	Sell	35,000 -15,000	-30%	-$393K	0.01%	306
2024 Q4	$1.26M	Buy	+50,000	New	+$1.28M	0.02%	252

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Raiffeisen Bank International's BEAM Position: Q1 2026 in Review

Raiffeisen Bank International increased its Beam Therapeutics (BEAM) stake by 4.7% in Q1 2026, buying an estimated $55.5K and bringing the position to 45,000 shares worth $986K. The position accounts for 0.01% of the portfolio, ranked #388.

Raiffeisen Bank International first reported a position in BEAM in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.26M in Q4 2024. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Raiffeisen Bank International held 45,000 shares of Beam Therapeutics worth $986K as of Q1 2026.
Raiffeisen Bank International bought 2,000 Beam Therapeutics shares in Q1 2026, an estimated $55.5K.
Beam Therapeutics made up 0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #388 holding.
Raiffeisen Bank International first reported a position in Beam Therapeutics in Q4 2024 and has held it in 6 quarters since.
Raiffeisen Bank International's Beam Therapeutics position peaked at $1.26M in Q4 2024.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.